<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00799916</url>
  </required_header>
  <id_info>
    <org_study_id>GEM 001</org_study_id>
    <nct_id>NCT00799916</nct_id>
  </id_info>
  <brief_title>Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis</brief_title>
  <official_title>Saline Solution Versus Voluven®: A Controlled Study of Fluid Resuscitation in Severe Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Nacional de La Plata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clínica Bazterrica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanatorio Otamendi y Miroli</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agencia de Promoción Científica y Tecnológica, Argentina, Proyecto PICT-2007-00912</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Nacional de La Plata</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fluid resuscitation of severe sepsis may consist of natural or artificial colloids or
      crystalloids. There is no evidence-based support for one type of fluid over another.

      The investigators hypothesis is that fluid resuscitation with Voluven® is advantageous to
      normal saline solution to improve sublingual microcirculation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Shock is the failure of circulatory system to maintain adequate cellular perfusion. Septic
      shock is primarily a form of distributive shock and is characterized by ineffective tissue
      oxygen delivery and extraction associated with inappropriate peripheral vasodilation despite
      preserved or increased cardiac output. In sepsis, a complex interaction between pathologic
      vasodilation, relative and absolute hypovolemia, myocardial dysfunction, and altered blood
      flow distribution occurs due to the inflammatory response to infection. Even after the
      restoration of intravascular volume, microcirculatory abnormalities may persist and lead to
      maldistribution of cardiac output.

      Notwithstanding the complexity of its pathophysiology and treatment, to maintain adequate
      organ perfusion is a main goal in the management of severe sepsis and septic shock. For this
      purpose, optimization of intravascular volume and preload is the more important step. Fluid
      challenge is a term used to describe the initial volume expansion period in which the
      response of the patient to fluid administration is carefully evaluated. During this process,
      large amounts of fluids may be administered over a short period of time under close
      monitoring to evaluate the patient's response and avoid the development of pulmonary edema.
      Fluid challenge should be given in all patients suspected of hypovolemia. Fluid resuscitation
      may consist of natural or artificial colloids or crystalloids. There is no evidence-based
      support for one type of fluid over another. As the volume of distribution is much larger for
      crystalloids than for colloids, resuscitation with crystalloids requires more fluid to
      achieve the same end points and might result in more edema. In addition, post-hoc analysis
      and experimental studies suggest that colloids might be superior to crystalloids, in terms of
      physiologic end-points, recruitment of the microcirculation and mortality.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sublingual microcirculation</measure>
    <time_frame>24 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gases, hemoglobin and oxygen saturations</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electrolytes and lactate</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anion gap corrected to albumin</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Voluven</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Resuscitation fluid: Voluven (R)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Resuscitation fluid: Saline solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Resuscitation (Voluven)</intervention_name>
    <description>Resuscitation aimed at venous oxygen saturation higher than 70%</description>
    <arm_group_label>Voluven</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Resuscitation (Saline)</intervention_name>
    <description>Resuscitation aimed at venous oxygen saturation higher than 70%</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe sepsis

        Exclusion Criteria:

          -  Age of less than 18 years

          -  Pregnancy, or the presence of an acute cerebral vascular event, acute coronary
             syndrome, acute pulmonary edema, status asthmatics

          -  Cardiac dysrhythmias (as a primary diagnosis), contraindication to central venous
             catheterization, active gastrointestinal hemorrhage, seizure

          -  Drug overdose, burn injury, trauma, a requirement for immediate surgery, uncured
             cancer (during chemotherapy

          -  Immunosuppression (because of organ transplantation or systemic disease),
             do-not-resuscitate status, advanced directives restricting implementation of the
             protocol

          -  Delayed admission to ICU from emergency department (more than 4 hours), or fluid
             resuscitation previous to ICU with more than 1,500 cc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaldo Dubin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanatorio Otamendi y Miroli</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinica Bazterrica</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clínica Santa Isabel</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanatorio Otamendi y Miroli</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2008</study_first_submitted>
  <study_first_submitted_qc>November 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2008</study_first_posted>
  <last_update_submitted>September 14, 2009</last_update_submitted>
  <last_update_submitted_qc>September 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Analía Pérez/Dirección de evaluación de medicamentos</name_title>
    <organization>Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT)</organization>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Fluid resuscitation</keyword>
  <keyword>Voluven</keyword>
  <keyword>Colloids</keyword>
  <keyword>Saline solution</keyword>
  <keyword>Crystalloids</keyword>
  <keyword>Sublingual microcirculation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

